Compounds of the formula (I), in which R
1
, R
2
, R
3
, R
4
, R
5
, B and X have the meanings indicated in claim
1
, are inhibitors of tyrosine kinases, in particular TIE-2, and Raf kinases and can be employed, inter alia, for the treatment of tumours.